top of page
Our Pipeline
Our Platform technology, is designed to support a comprehensive portfolio of first in class products, delivered in both topical & oral formats. Our R&D efforts focus on areas, where significant unmet needs exists, and where the natural product has shown substantial efficacy in pre-clinical models and/or humans.
Clinical Development Roadmap
Metabolic Syndrome & Obesity
Condition
Preclinical
Clinical
Compound
IND-Enabling
DS 0111
Skin Aging Topicl
DS 0121
Skin Inflammatory. Conditions
DS 0131
DS 0141
Mood Disorder
DS 0142
Cognitive Disoder
DS 0151
Solid Tumors
DS 0151
Atopic Dermatitis
DS 0161
Respiratory
DS 0161
Mood & Skin
A Deeper Dive into our Product Proposals
bottom of page